Literature DB >> 8033038

The role of basement membrane in colorectal cancer invasion and liver metastasis.

J Hida1, T Matsuda, M Kitaoka, N Machidera, R Kubo, M Yasutomi.   

Abstract

BACKGROUND: Basement membrane (BM) is a specialized extracellular matrix component that plays a key role in tumor invasion and metastasis.
METHODS: Immunohistochemical staining for two major components of BM, type IV collagen (C IV), and laminin (LN), utilizing avidin-biotin-peroxidase complex detection to examine 182 primary colorectal cancers (pT2 or greater) and 20 liver metastases.
RESULTS: The distribution of C IV was the same as of LN in colorectal cancer tissue, and in normal tissue. Both C IV and LN staining were more frequently positive in the superficial zone but infrequently in the deep zone of the primary tumor. BM preservation, C IV and LN staining in both the superficial and deep zones, was seen in 18.7% of the subjects. The rate of BM preservation significantly decreased with increasing histologic grade (P < 0.01). No correlation was observed between pT number and BM preservation. The rate of BM preservation in cases of liver metastasis was 84.4%, significantly higher than the rate in cases without liver metastasis (P < 0.001). BM was observed even at the advancing front of tumor invasion and was preserved in 95.0% of the liver metastases.
CONCLUSIONS: BM is a functional substance that appears to accompany cancer rather than function as a structural barrier against cancer invasion and liver metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033038     DOI: 10.1002/1097-0142(19940715)74:2<592::aid-cncr2820740210>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy?

Authors:  M Hagenaars; N G Ensink; P H Basse; M Hokland; U Nannmark; A M Eggermont; C J van de Velde; G J Fleuren; P J Kuppen
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype.

Authors:  T Tani; T Karttunen; T Kiviluoto; E Kivilaakso; R E Burgeson; P Sipponen; I Virtanen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma.

Authors:  T L Davis; A E Cress; B L Dalkin; R B Nagle
Journal:  Prostate       Date:  2001-02-15       Impact factor: 4.104

4.  Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential.

Authors:  Bo Tian; Yan Li; Xue-Ning Ji; Jie Chen; Qiong Xue; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-12       Impact factor: 4.553

5.  Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide.

Authors:  Katherine L Morel; Rebecca J Ormsby; Emma L Solly; Linh N K Tran; Christopher J Sweeney; Sonja Klebe; Nils Cordes; Pamela J Sykes
Journal:  Clin Exp Metastasis       Date:  2018-06-23       Impact factor: 5.150

6.  Label-free imaging of basement membranes differentiates normal, precancerous, and cancerous colonic tissues by second-harmonic generation microscopy.

Authors:  Shuangmu Zhuo; Jun Yan; Gang Chen; Hong Shi; Xiaoqin Zhu; Jianping Lu; Jianxin Chen; Shusen Xie
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

7.  Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients.

Authors:  Hatem A El-Mezayen; El-Shahat A Toson; Hossam Darwish; Ehab El-Badry
Journal:  Tumour Biol       Date:  2012-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.